Fauna Bio

Pharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh

Ashley Zehnder, an exotic animal veterinarian and cancer biologist, co-founded Fauna Bio in 2018, after recognizing the potential to translate insights from non-human mammalian biology into human ther

Novo Nordisk ’s Wegovy and Eli Lilly ’s Zepbound have turned weight loss treatments into a multi-billion-dollar field but the sector is already looking to new approaches to see where cardiometabolic

The extent to which artificial intelligence (AI) and technology are fundamentally altering the research and development game came through during a panel discussion by Eli Lilly and Company ’s chief i